Multiple Ascending Dose Study in Healthy Subjects
NCT03879278
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class
Stopped
Mild infusion reactions were observed in two healthy volunteers.
Conditions
Amyloidosis
Interventions
DRUG:
NPT189
Sponsor
Proclara Biosciences, Inc.